Models for 10,000 Human Diseases
In Vitro Blood Brain Barrier Models for Drug Development
Welcome back to our blog series about the blood brain barrier (BBB). In Part 1, we provided a brief history on the discovery of the BBB, and introduced what we currently know about its composition and biological functions. In Part 2, we explain why reliable BBB models...
Tempo-iMG™ and Tempo-iOligo™: Two New Puzzle Pieces
Tempo-iMG™ and Tempo-iOligo™ were cited by scientists in a nature.com study where they built a 3D in vitro organoid model of the blood brain barrier (BBB). They chose to build their BBB model based on a composition of multiple neural and glial cell types. By utilizing...
What is the Blood Brain Barrier? Part 1 of a Series
Welcome to our new blog series about the blood brain barrier (BBB)! In Part 1, we will give a brief history on the discovery of the BBB, as well as introduce what we know about its composition and biological functions. The blood brain barrier or BBB is a highly...
Tempo-iMG™: Targeting Solutions for HIV
Tempo-iMG™, human iPSC-derived microglia, was used in a follow-up study cited in plos.org. This study expanded on a previous discovery showing that healthy microglia were able to silence HIV. Citation Summary In the current study, scientists from Case Western Reserve...
Tempo-iMG™, Tempo-iCort™, Tempo-iDopaNer™, and Tempo-iMotorNer™ Communication is Key
Tempo-iMG™, Tempo-iCort™, Tempo-iDopaNer™, and Tempo-iMotorNer™ were utilized in a study cited in plos.org that examined the cross-talking relationship between microglia and neurons. It was critical that the researchers deployed Tempo’s iPSC-derivative cell types to...
Tempo Bioscience Services
Disease Models and Assay Services
Tempo offers services and alliances based on our advanced technological platforms and a range of capabilities. Our team differentiates ourselves based on a strong commitment to innovative solutions and quality R&D for our partners.
Tempo Bioscience Support
On Demand Custom Engineered Cell Models
Tempo develops patient relevant stem cell (iPSCs) based models to support drug discovery, preclinical studies, and early-stage clinical development.